Wolinsky Howard
Manag Care. 2018 Jul;27(7):21-24.
The time may finally be here for standalone continuous glucose monitors. It's been a long road. Medicare and consumer health plans were slow to cover them, but now the FDA has approved four such devices. Experts expect that nearly 3 million Americans will be able to use the devices.
独立式连续血糖监测仪的时代或许终于来临了。这一路走来颇为漫长。医疗保险和消费者健康计划对其覆盖进展缓慢，但如今美国食品药品监督管理局（FDA）已批准了四款此类设备。专家预计，近300万美国人将能够使用这些设备。
